ProMetic Life Sciences Inc.

ProMetic Life Sciences Inc.

ProMetic Life Sciences Inc. (TSX-PLI.SV) is a biopharmaceutical company specialized in the research, development, manufacture and marketing of a variety of commercial applications derived from its proprietary Enabling Technology. Mimetic LigandTM technology is used in large-scale purification of biologics and the elimination of pathogens/viruses. ProMetic is also active in Therapeutic Drug Development with the mission to bring to market effective, innovative, lower cost, less toxic products for the treatment of inflammation and cancer. The Companys Mimetic LigandTM technology is also leveraged into its drug discovery platform aiming at replacing complex, expensive proteins with synthetic drug-like protein mimetics. Headquartered in Montreal (Canada), ProMetic has R&D and manufacturing facilities in the UK and business development activities in the US, Europe, Asia and MENA countries (Middle East and North Africa).

Company Details

Year Established: 1994

Number of Employees: 117

Company Information

Pierre Laurin
Title: President
Telephone: (514) 496-2115
Fax: (514) 341-6227
Email: Click Here

Lise H. Van Chestein
Title: Admin/Exec Assistant
Area of Responsibility: Administrative Services
Telephone: (514) 341-2115
Fax: (514) 341-6227
Email: Click Here

Products

Combinational Chemistry

Solid Phase Screening

Agaroes And Perfluorocarbon Beads Technology

Extracorporeal Medical Devices To Remove Therapeutics And Biocontaminants, Toxins

Diagnostic Kits

Drug Delivery System For Proteomics, Genomics And Other Therapeutics

Services